ATX-101 potentiates activity of chemotherapy in preclinical studies by disrupting cell cycle control March 14, 2011
Genentech reports moderate to low risk of interactions between GDC-0941 and paclitaxel March 11, 2011
First-in-human data on TUTI-16 support its use in asymptomatic HIV-1-infected subjects March 11, 2011